CAP Centelles

At CAP Centelles the Family and Community Medicine department is investigating ways to reduce bleeding after dental procedures in patients on anticoagulant therapy. The study evaluates an oral solution of tranexamic acid to improve postoperative outcomes for individuals undergoing single or multiple tooth extractions.

• Evaluation of bleeding control strategies during dental extractions
• Impact of anticoagulant medication on oral surgery outcomes
• Patient safety and recovery after tooth removal

The site, located in Centelles, Spain, currently supports two clinical investigations with a dedicated investigator, emphasizing patient‑centered care in oral health and anticoagulation management.

Researchers at CAP Centelles are also conducting a vaccine study aimed at protecting against the SARS‑CoV‑2 Omicron variant. The trial measures the safety profile and immune response generated by the experimental vaccine BIMERVAX® XFG.1.1.

• Assessment of vaccine safety in healthy volunteers
• Measurement of immunogenicity against the Omicron strain
• Monitoring of adverse events post‑vaccination

This effort reflects the site’s commitment to addressing emerging viral threats, with the same two‑trial portfolio contributing to broader public health goals in Europe.